Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 AUD | +11.11% |
|
0.00% | -42.86% |
05-22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
05-20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
11.51M | - | - | - | - | - | |
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.91B |